Recently, molecular alterations in ERBB4/HER4/ALS19 receptors (loss of function) have been linked to several neurological diseases such as ALS and schizophrenia [8, 9, 11, 22, 37]. Here, ERBB4 is linked to amyotrophic lateral sclerosis.